title: Reversal of multidrug resistance.
authors: Medicine Branch, National Cancer Institute, Bethesda, MD 20892.
authors: S E
authors: SE
authors: Bates
authors: Z
authors: Z
authors: Zhan
authors: B
authors: B
authors: Dickstein
authors: J S
authors: JS
authors: Lee
authors: S
authors: S
authors: Scala
authors: A T
authors: AT
authors: Fojo
authors: K
authors: K
authors: Paull
authors: W
authors: W
authors: Wilson
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors / Q000235:genetics; D000970:Antineoplastic Agents / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D018432:Drug Resistance, Multiple / Q000235:genetics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000633:toxicity; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology; D014750:Vincristine / Q000633:toxicity
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D014750:Vincristine; D014700:Verapamil; D017239:Paclitaxel